Tech Company Financing Transactions
Rakuten Aspyrian Funding Round
Rakuten Aspyrian, based in San Diego, secured $134 million from Rakuten and SBI Holding.
Transaction Overview
Company Name
Announced On
12/24/2018
Transaction Type
Venture Equity
Amount
$134,000,000
Round
Series C
Investors
SBI Holding (Yoshitaka Kitao)
Proceeds Purpose
The Series C financing supports the advancement of Rakuten Aspyrian's proprietary investigational compound, ASP-1929 Photoimmunotherapy, currently in Phase 3 development for the treatment of patients with recurrent local regional head and neck squamous cell carcinomas (HNSCC), and new proof-of-concept Phase 1/2 studies in additional solid tumors to be initiated in early 2019. The financing will also support manufacturing processes to support the initial launch and commercialization of ASP-1929 if approved in the United States, Japan and Europe.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11080 Roselle St.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Rakuten Aspyrian, Inc., is a privately funded clinical stage biotechnology company with offices in the USA, Japan and Germany. Rakuten Aspyrian has been developing new anticancer therapies based on the Photoimmunotherapy platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Hiroshi Mikitani
Chief Executive Officer
Miguel Garcia-Guzman
Chief Medical Officer
Merrill Biel
Chief Technical Officer
Carlos Garcia
VP - Bus. Development
Abhijit Bhatia
VP - Finance
Agatha Martindale
VP - General Counsel
Isaac Dye
VP - Human Resources
Suzane San
VP - Operations
Lola Fong
VP - Operations
Minami Maeda
Browse more venture capital transactions:
Prev: 12/24/2018: Allbound venture capital transaction
Next: 12/24/2018: SmartHop venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs